BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37340044)

  • 1. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
    Rong W; Shao S; Pu Y; Ji Q; Zhu H
    Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
    Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
    Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles.
    Kuhn M; Zhang Y; Favate J; Morita M; Blucher A; Das S; Liang S; Preet R; Parham LR; Williams KN; Molugu S; Armstrong RJ; Zhang W; Yang J; Hamilton KE; Dixon DA; Mills G; Morgan TK; Shah P; Andres SF
    Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G571-G585. PubMed ID: 36194131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
    Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
    J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
    Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
    EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicle-Transported Long Non-Coding RNA (LncRNA) X Inactive-Specific Transcript (XIST) in Serum is a Potential Novel Biomarker for Colorectal Cancer Diagnosis.
    Yu J; Dong W; Liang J
    Med Sci Monit; 2020 Aug; 26():e924448. PubMed ID: 32843612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma miR-1, but not Extracellular Vesicle miR-1, Functions as a Potential Biomarker for Colorectal Cancer Diagnosis.
    Xu B; Shen X; Yang Z; Zhao T; Liu B; Gao S; Shi Y; Bao C
    Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jianpi Jiedu Recipe inhibits colorectal cancer liver metastasis via regulating ITGBL1-rich extracellular vesicles mediated activation of cancer-associated fibroblasts.
    Li R; Zhou J; Wu X; Li H; Pu Y; Liu N; Han Z; Zhou L; Wang Y; Zhu H; Yang L; Li Q; Ji Q
    Phytomedicine; 2022 Jun; 100():154082. PubMed ID: 35381565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
    Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T
    Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.
    Lee CH; Im EJ; Moon PG; Baek MC
    BMC Cancer; 2018 Nov; 18(1):1058. PubMed ID: 30382917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of plasma LC3B
    Chen YQ; Zheng L; Zhou J; Wang P; Wang L; Zhang Y; Man ZS; Chen YH; Gu F; Niu GP
    Int Immunopharmacol; 2022 Jul; 108():108760. PubMed ID: 35398623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of exosomes derived from colorectal cancer as a biomarker.
    Xiao Y; Li Y; Yuan Y; Liu B; Pan S; Liu Q; Qi X; Zhou H; Dong W; Jia L
    Clin Chim Acta; 2019 Mar; 490():186-193. PubMed ID: 30194933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer.
    Wang W; Qu A; Liu W; Liu Y; Zheng G; Du L; Zhang X; Yang Y; Wang C; Chen X
    Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26898324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal Cancer-Derived CAT1-Positive Extracellular Vesicles Alter Nitric Oxide Metabolism in Endothelial Cells and Promote Angiogenesis.
    Ikeda A; Nagayama S; Sumazaki M; Konishi M; Fujii R; Saichi N; Muraoka S; Saigusa D; Shimada H; Sakai Y; Ueda K
    Mol Cancer Res; 2021 May; 19(5):834-846. PubMed ID: 33579815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Small Extracellular Vesicles in the Progression of Colorectal Cancer and Its Clinical Applications.
    Chang LC; Chiu HM; Wu MS; Shen TL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
    Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
    Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
    Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
    J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer.
    Wang Y; Fang YX; Dong B; Du X; Wang J; Wang X; Gao WQ; Xue W
    Theranostics; 2021; 11(2):878-892. PubMed ID: 33391510
    [No Abstract]   [Full Text] [Related]  

  • 19. Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
    Nakurte I; Jekabsons K; Rembergs R; Zandberga E; Abols A; Linē A; Muceniece R
    Anticancer Res; 2018 Nov; 38(11):6133-6138. PubMed ID: 30396929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MARCKSL1 interacted with F-actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia.
    Zhao Y; Xie X; Tian L; Liu F; Sun Y; Lu H; Zhao X; Mao Y
    Cancer Med; 2023 Feb; 12(3):3299-3312. PubMed ID: 35894387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.